Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>IMS</strong> COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING<br />
De scrip tion: Dis trib u tor, pro moter. Prod uct<br />
ranges in clude: phar ma ceu ti cal products.<br />
NOVEXAL<br />
Full Name: NOVEXAL Ellas Ltd.<br />
Street Ad dress: Ag. Dimitrou 25, GR-174 55<br />
Alimos<br />
Tel: +30 10 9828 876<br />
Fax: +30 10 9827 211<br />
Email: novexal@otenet.gr<br />
De scrip tion: Es tab lished 2001.<br />
Con tacts (Pharm): Chair man: Thalia Koukidou;<br />
Gen eral Con tact: Thalia Koukidou<br />
Sub sid iary of: Sandoz, Ger many<br />
GUATEMALA<br />
NOVARTIS<br />
Full Name: Novartis Farmaceutica SA (ACC),<br />
Cen tral Amer ica & The Ca rib bean<br />
Postal Ad dress: Apartado Postal 1115, 01011<br />
Gua te mala City<br />
Street Ad dress: Anillo Periferico 30-31, Zona 11,<br />
01011 Gua te mala City<br />
Tel: +502 242-28-400<br />
Fax: +502 242-28-401<br />
De scrip tion: Im porter, dis trib u tor, pro moter,<br />
sales/detailer. Im ports, dis trib utes, pro motes,<br />
sells/de tails for other com pa nies. Prod uct ranges<br />
in clude: phar ma ceu ti cal prod ucts (branded, pre -<br />
scrip tion, non-pre scrip tion), oph thal mic prod ucts,<br />
vet er i nary pharmaceuticals. Es tab lished 1967.<br />
250 phar ma ceu ti cal em ploy ees in 2006. Di vi sions<br />
in clude: An i mal Health; Con sumer Health;<br />
Pharma; Oncology; Ophthalmics; Transplant.<br />
Rep re sen ta tives/De tail ers (Pharm, Num -<br />
ber): 101-500 (2006)<br />
Con tacts (Pharm): Chair man: Pi erre Werren;<br />
Com mer cial Op er a tions: Luis Roberto Torres;<br />
Mar ket Re search: Marco An to nio Mar ti nez; Gen -<br />
eral Con tact: Marco An to nio Martinez<br />
Phar ma ceu ti cal Sales: US$ 35-40 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 60-65%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 80-85%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
95-100%<br />
Prin ci pal Prod ucts:<br />
CATAFLAM (antirheumatic non-steroidal)<br />
CO-DIOVAN (an gio ten sin-II an tag o nist com bi na -<br />
tion)<br />
DIOVAN (an gio ten sin-II an tag o nist plain)<br />
PANTECTA (antiulcerant)<br />
VOLTAREN (antirheumatic non-steroidal)<br />
Ther a peu tic Range:<br />
anti rheu ma tics sys temic 35%<br />
renin-an gio ten sin sys tem agents 27%<br />
ant ac ids/antiflatulents/antiulcerants 10%<br />
antiepileptics 7%<br />
antiasthma and COPD prod ucts 4%<br />
Lead ing Dose Forms:<br />
coated tab lets 50%<br />
tab lets 19%<br />
cap sules 12%<br />
liq uids 9%<br />
am poules 5%<br />
HONDURAS<br />
NOVARTIS CON SUMER HEALTH<br />
Street Ad dress: Colonia Alameda, Casa No<br />
1104, Tegu ci gal pa<br />
Tel: +504 232-7337<br />
Fax: +504 232-4886<br />
Phar ma ceu ti cal Sales: US$ 8-9 mil lion<br />
Prod ucts (% of Sales by Lead ing 5): 60-65%<br />
Ther a peu tic Classes (% of Sales by Lead ing<br />
5): 80-85%<br />
Dose Forms (% of Sales by Lead ing 5):<br />
80-85%<br />
Prin ci pal Prod ucts:<br />
ESPASMO CANULASE (di ges tive in clud ing en -<br />
zymes)<br />
VOLTAREN EMULGEL (antirheumatic top i cal)<br />
LAMISIL TOPIC (dermatological antifungal)<br />
MEBOCAINA WT (throat prep a ra tion)<br />
MEBOCAINA (throat prep a ra tion)<br />
Ther a peu tic Range:<br />
di ges tives in clud ing di ges tive en zymes 20%<br />
cough and cold prep a ra tions 18%<br />
anti rheu ma tics top i cal 16%<br />
throat prep a ra tions 15%<br />
dermatological antifungals 13%<br />
Lead ing Dose Forms:<br />
tab lets 26%<br />
gels/sols 18%<br />
spe cial solid forms 16%<br />
liq uids 14%<br />
creams 10%<br />
© 2009 <strong>IMS</strong> Health In cor po rated or its af fil i ates Page 174